Table 2.
Spot (peptide) |
Region | IgG | IgM | IgA |
---|---|---|---|---|
5 | S1A | −/+ | +++/+++ | +/++ |
17 | S1C | −/+++ | +++/+++ | −/+++ |
18* | S1C | ++/++ | +/++ | +++/++ |
20* | S1C | −/− | −/− | ++/− |
21 | S1C | +++/+++ | +/+++ | +++/+++ |
22 | S1C | −/− | ++/++ | −/− |
23 | S1C | +++/− | −/− | −/− |
32 | S2 | −/− | +++/+++ | −/++ |
34 | S2 | −/− | ++/++ | −/− |
37 | S2 | ++/+++ | −/− | −/− |
39 | RBD | −/− | +++/+++ | −/− |
41 | RBD | −/− | ++/++ | −/− |
43 | RBD | −/− | ++/++ | −/++ |
49 | RBD | ++/+++ | +++/+++ | −/+++ |
52 | RBD | −/− | +++/+++ | −/− |
54 | RBD | −/− | −/− | −/++ |
62 | RBD | −/− | −/− | −/+++ |
Results Pool 1/Pool 2. “+” denotes positive result; number of “+” signifies relative increase in positive spot intensity in the membrane; “−” denote negative result. Chemical control spots, 61 and 62, are repetition of peptides 54 and 55. ⁎ Peptides of SARS-CoV.